Seema K Pursnani, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pursnani’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$879
Medicare paid this office $879 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 71 · Health risk score 2.38. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 65% · Heart failure 65%.
The office billed $3,528, Medicare allowed $1,103 and paid $879; for 22 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 22 | 71 | 2.38 | $3,528 | $879 |
| 2023 | 23 | 29 | 70 | 1.93 | $5,185 | $1,128 |
| 2022 | 32 | 47 | 68 | 2.41 | $10,292 | $2,468 |
| 2021 | 17 | 25 | 72 | 3.58 | $3,194 | $848 |
| 2020 | 31 | 42 | 69 | 2.62 | $8,020 | $1,843 |
| 2019 | 43 | 49 | 71 | 3.42 | $5,631 | $1,433 |
| 2018 | 72 | 94 | 71 | 2.97 | $11,495 | $2,694 |
| 2017 | 84 | 116 | 68 | 2.49 | $10,133 | $2,217 |
| 2016 | 40 | 50 | 69 | 2.85 | $5,857 | $1,372 |
| 2015 | 48 | 63 | 67 | 2.43 | $8,545 | $1,927 |
| 2013 | 38 | 67 | 75 | 2.89 | $15,776 | $4,216 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $95 | $7 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $120 | $7 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $84 | $6 |
2020: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $140 | $6 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $274 | $8 |
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 52 | $402 | $6 |
2017: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 66 | $509 | $6 |
2016: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $179 | $7 |
2015: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 33 | $283 | $7 |
2013: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,435 | $62 |
Medicaid work
$886 in 2024
Medicaid paid $886 for 126 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 126 | $886 |
| 2024 | 126 | 1 | 42 | $886 |
| 2023 | 58 | 1 | 23 | $148 |
| 2022 | 49 | 1 | 18 | $106 |
| 2021 | 111 | 1 | 30 | $229 |
| 2020 | 133 | 1 | 22 | $273 |
| 2019 | 120 | 1 | 22 | $151 |
| 2018 | 282 | 1 | 39 | $889 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 58 | $148 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 49 | $106 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 111 | $229 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 133 | $273 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 120 | $151 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 282 | $889 |
Drugs they prescribed that Part D paid
$334,451
Pharmacies billed $334,451 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,188) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
925 generic and 263 brand-name prescriptions · $334,451 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 46 | $60,587 | $1,317 |
| Jardiance | 103 | $53,601 | $520 |
| Eliquis | 29 | $52,720 | $1,818 |
| Repatha Sureclick | 26 | $20,315 | $781 |
| Icosapent Ethyl | 43 | $16,067 | $374 |
See all 22 drugs
| Entresto | 46 | $60,587 | $1,317 |
| Jardiance | 103 | $53,601 | $520 |
| Eliquis | 29 | $52,720 | $1,818 |
| Repatha Sureclick | 26 | $20,315 | $781 |
| Icosapent Ethyl | 43 | $16,067 | $374 |
| Pradaxa | 36 | $10,764 | $299 |
| Amiodarone | 90 | $3,089 | $34 |
| Atorvastatin | 104 | $1,282 | $12 |
| Furosemide | 89 | $1,267 | $14 |
| Metoprolol | 96 | $1,189 | $12 |
| Metoprolol | 72 | $1,066 | $15 |
| Sotalol | 36 | $981 | $27 |
| Flecainide Acetate | 23 | $743 | $32 |
| Isosorbide Mononitrate Er | 26 | $562 | $22 |
| Ezetimibe | 46 | $537 | $12 |
| Spironolactone | 46 | $496 | $11 |
| Carvedilol | 38 | $411 | $11 |
| Losartan | 32 | $386 | $12 |
| Rosuvastatin | 27 | $311 | $12 |
| Hydralazine | 17 | $311 | $18 |
| Lisinopril | 22 | $303 | $14 |
| Amlodipine Besylate | 17 | $295 | $17 |
Year by year
| 2024 | 1,188 | 249 | 0% (0) | 22% | $334,451 |
| 2023 | 1,018 | 207 | 0% (0) | None | $317,073 |
| 2022 | 796 | 185 | 0% (0) | 29% | $299,507 |
| 2021 | 561 | 139 | 0% (0) | 19% | $98,352 |
| 2020 | 475 | 121 | 0% (0) | 23% | $60,962 |
| 2019 | 453 | 147 | 0% (0) | 20% | $56,683 |
| 2018 | 719 | 164 | None | 30% | $62,437 |
| 2017 | 624 | 142 | 0% (0) | 31% | $38,042 |
| 2016 | 438 | 116 | None | 31% | $25,419 |
| 2015 | 254 | 87 | None | 28% | $13,275 |
| 2014 | 69 | 32 | 0% (0) | 32% | $3,262 |
| 2013 | 79 | 30 | None | 30% | $5,395 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Entresto | 43 | $58,064 | $1,350 |
| Jardiance | 79 | $51,838 | $656 |
| Eliquis | 25 | $41,801 | $1,672 |
| Vascepa | 40 | $28,120 | $703 |
| Pradaxa | 24 | $7,208 | $300 |
| Amiodarone | 102 | $3,419 | $34 |
| Atorvastatin | 90 | $1,919 | $21 |
| Metoprolol | 91 | $1,435 | $16 |
| Furosemide | 73 | $1,100 | $15 |
| Flecainide Acetate | 24 | $898 | $37 |
| Losartan | 26 | $594 | $23 |
| Metoprolol | 56 | $571 | $10 |
| Sotalol | 19 | $564 | $30 |
| Carvedilol | 36 | $461 | $13 |
| Spironolactone | 43 | $449 | $10 |
| Lisinopril | 26 | $383 | $15 |
| Ezetimibe | 32 | $373 | $12 |
| Rosuvastatin | 24 | $358 | $15 |
| Isosorbide Mononitrate Er | 14 | $344 | $25 |
| Hydralazine | 13 | $249 | $19 |
| Amlodipine Besylate | 14 | $203 | $15 |
2022: 21 drugs
| Entresto | 31 | $38,080 | $1,228 |
| Eliquis | 24 | $36,255 | $1,511 |
| Vascepa | 36 | $30,473 | $846 |
| Jardiance | 37 | $23,824 | $644 |
| Pradaxa | 15 | $7,178 | $479 |
| Amiodarone | 62 | $2,364 | $38 |
| Flecainide Acetate | 37 | $1,991 | $54 |
| Atorvastatin | 72 | $1,408 | $20 |
| Metoprolol | 45 | $876 | $19 |
| Sotalol | 23 | $846 | $37 |
| Furosemide | 56 | $842 | $15 |
| Metoprolol | 45 | $590 | $13 |
| Isosorbide Mononitrate Er | 23 | $466 | $20 |
| Carvedilol | 37 | $461 | $12 |
| Rosuvastatin | 24 | $448 | $19 |
| Ezetimibe | 16 | $442 | $28 |
| Spironolactone | 28 | $325 | $12 |
| Clopidogrel | 15 | $307 | $20 |
| Lisinopril | 19 | $284 | $15 |
| Losartan | 18 | $245 | $14 |
| Amlodipine Besylate | 13 | $185 | $14 |
2021: 16 drugs
| Eliquis | 17 | $19,356 | $1,139 |
| Entresto | 15 | $17,346 | $1,156 |
| Jardiance | 15 | $9,279 | $619 |
| Amiodarone | 45 | $1,744 | $39 |
| Atorvastatin | 76 | $1,425 | $19 |
| Flecainide Acetate | 19 | $1,217 | $64 |
| Ezetimibe | 20 | $909 | $45 |
| Sotalol | 16 | $732 | $46 |
| Metoprolol | 45 | $618 | $14 |
| Metoprolol | 25 | $610 | $24 |
| Rosuvastatin | 22 | $570 | $26 |
| Furosemide | 30 | $431 | $14 |
| Carvedilol | 21 | $308 | $15 |
| Nitroglycerin | 11 | $271 | $25 |
| Losartan | 17 | $206 | $12 |
| Spironolactone | 14 | $153 | $11 |
2020: 13 drugs
| Eliquis | 38 | $25,800 | $679 |
| Amiodarone | 42 | $1,548 | $37 |
| Atorvastatin | 58 | $1,056 | $18 |
| Ezetimibe | 21 | $956 | $46 |
| Furosemide | 45 | $792 | $18 |
| Flecainide Acetate | 17 | $771 | $45 |
| Rosuvastatin | 18 | $452 | $25 |
| Metoprolol | 21 | $433 | $21 |
| Carvedilol | 24 | $350 | $15 |
| Metoprolol | 24 | $272 | $11 |
| Hydralazine | 11 | $258 | $23 |
| Losartan | 16 | $223 | $14 |
| Spironolactone | 12 | $208 | $17 |
2019: 11 drugs
| Eliquis | 19 | $21,061 | $1,108 |
| Pradaxa | 11 | $6,121 | $556 |
| Atorvastatin | 70 | $1,821 | $26 |
| Amiodarone | 35 | $1,418 | $41 |
| Ezetimibe | 13 | $818 | $63 |
| Carvedilol | 40 | $504 | $13 |
| Furosemide | 31 | $426 | $14 |
| Clopidogrel | 15 | $376 | $25 |
| Metoprolol | 26 | $262 | $10 |
| Spironolactone | 14 | $220 | $16 |
| Losartan | 11 | $108 | $10 |
2018: 17 drugs
| Pradaxa | 34 | $20,977 | $617 |
| Atorvastatin | 92 | $2,823 | $31 |
| Dilt-Xr | 21 | $1,665 | $79 |
| Flecainide Acetate | 14 | $1,226 | $88 |
| Carvedilol | 83 | $1,014 | $12 |
| Furosemide | 59 | $925 | $16 |
| Clopidogrel | 32 | $888 | $28 |
| Metoprolol | 87 | $869 | $10 |
| Amiodarone | 31 | $781 | $25 |
| Hydralazine | 11 | $573 | $52 |
| Isosorbide Mononitrate Er | 25 | $570 | $23 |
| Lisinopril | 31 | $493 | $16 |
| Pravastatin | 14 | $442 | $32 |
| Losartan | 16 | $288 | $18 |
| Atenolol | 11 | $218 | $20 |
| Amlodipine Besylate | 22 | $179 | $8 |
| Spironolactone | 11 | $126 | $11 |
2017: 17 drugs
| Pradaxa | 27 | $13,920 | $516 |
| Atorvastatin | 60 | $1,912 | $32 |
| Amiodarone | 34 | $944 | $28 |
| Metoprolol | 91 | $940 | $10 |
| Furosemide | 67 | $936 | $14 |
| Dilt-Xr | 12 | $936 | $78 |
| Hydralazine | 13 | $776 | $60 |
| Clopidogrel | 26 | $773 | $30 |
| Pravastatin | 22 | $762 | $35 |
| Carvedilol | 59 | $721 | $12 |
| Isosorbide Mononitrate Er | 27 | $605 | $22 |
| Lisinopril | 27 | $336 | $12 |
| K-Tab Er | 11 | $284 | $26 |
| Losartan | 14 | $284 | $20 |
| Atenolol | 16 | $264 | $17 |
| Amlodipine Besylate | 15 | $119 | $8 |
| Spironolactone | 11 | $113 | $10 |
2016: 10 drugs
| Pradaxa | 27 | $12,071 | $447 |
| Atorvastatin | 36 | $1,310 | $36 |
| Amiodarone | 35 | $1,029 | $29 |
| Furosemide | 55 | $710 | $13 |
| Isosorbide Mononitrate Er | 16 | $677 | $42 |
| Carvedilol | 51 | $600 | $12 |
| Metoprolol | 56 | $590 | $11 |
| Pravastatin | 11 | $464 | $42 |
| Losartan | 14 | $385 | $27 |
| Lisinopril | 21 | $284 | $14 |
2015: 9 drugs
| Pradaxa | 11 | $4,372 | $397 |
| Atorvastatin | 20 | $724 | $36 |
| Isosorbide Mononitrate Er | 12 | $433 | $36 |
| Metoprolol | 36 | $338 | $9 |
| Amiodarone | 11 | $332 | $30 |
| Carvedilol | 29 | $323 | $11 |
| Losartan | 11 | $260 | $24 |
| Furosemide | 20 | $254 | $13 |
| Spironolactone | 14 | $156 | $11 |
2013: 2 drugs
| Xarelto | 13 | $3,481 | $268 |
| Metoprolol | 13 | $318 | $24 |
Money from drug and device companies
$16 in 2021
A payment is not proof that care is biased.
| Boston Scientific | Watchman | $16 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2021-04-08 | Watchman | $16 |
Professional record
- NPI
- 1902052913
- Licence
- NY 249457-1
- Trained
- New York University School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 166 2nd Ave Apt 9d, New York, NY, 10003
- NPI first listed
- 2008-08-09
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.